Not finding it? Sign in to also search OpenAlex live.
-
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial2022 Transplantation Direct article Medicine Renal Transplantation Outcomes and Treatments Open access
Jan Hinrich Bräsen, Maarten Naesens, Dany Anglicheau, Pierre P. Marquet, Klemens Budde, Mareen Matz
14citations -
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies2022 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Clifton O. Bingham, David Walker, Peter T. Nash, Sang Hyuck Lee, Lei Ye, Hao Hu, +2 more
10citations -
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III2025 Cardiovascular Diabetology article Medicine Atrial Fibrillation Management and Outcomes Open access
Giulio Francesco Romiti, Davide Antonio Mei, Bernadette Corica, Marco Proietti, Giuseppe Boriani, Brian Olshansky, +3 more
8citations -
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis
Judith S. E. Quik, Marieke A. Vollebergh, Valesca P. Retèl, Karen van der Sluis, Willem J. Koemans, Rosa T. van der Kaaij, +18 more
8citations -
Safety and functional outcome analysis of ventriculoperitoneal shunt placement for hydrocephalus within the critical phase of possible delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Julien Jost, Yasin Irmak, Basil Erwin Grüter, Angelo Tortora, Serge Marbacher, Christian Musahl, +3 more
4citations -
738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial2024 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments Open access
Sven� Mahner, Fabian Trillsch, Janice S. Kwon, Sarah Elizabeth Ferguson, Paul Bessette, Gwénaël Ferron, +14 more
3citations -
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
Paolo Giovanni Nuciforo, John Townend, Cristina Saura, E. de Azumbaja, Florentine Hilbers, Anna Manukyants, +13 more
3citations -
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial2025 Obstetrical & Gynecological Survey article Medicine Endometrial and Cervical Cancer Treatments Open access
Cathalijne Post, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, +23 more
1citations -
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis2025 European Journal of Cancer article Mathematics Statistical Methods in Clinical Trials Open access
Alexander Dean Sherry, Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, +6 more
1citations -
Nefecon treatment response in asian and white patient populations with immunoglobulin a nephropathy: a 2year analysis of the phase iii nefigard trial2024 RWTH Publications (RWTH Aachen) article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Flöge, Vladimír Tesař, Hernán Trimarchi, +6 more
0citations -
#1706771 Oral octreotide capsules for treatment of acromegaly: a post hoc analysis of biochemical efficacy and safety using a pooled phase 3 clinical trial dataset
Susan Leanne Samson, Maria Fleseriu, Nienke Ruurdje Biermasz, Christian Joseph Strasburger, Shir Fuchs Orenbach, Jason A. Crompton, +1 more
0citations -
21P: Primary analysis of safety, efficacy and immunogenicity of the therapeutic cancer vaccine PDC*lung01 with or without pembrolizumab in NSCLC: A multicenter phase I/II study2025 Journal of Thoracic Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, I. Demedts, K. Cuppens, Elvire Pons Tostivint, E. Wauters, Frank Johannes Borm, +13 more
0citations -
Nefecon treatment provides kidney benefits for patients with igan that extend to those with low levels of UPCR: a sub-analysis of the phase III nefigard trial2024 RWTH Publications (RWTH Aachen) article Medicine Chronic Kidney Disease and Diabetes Open access
Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Flöge, Vladimír Tesař, Hernán Trimarchi, +6 more
0citations -
POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study2023 Clinical Lymphoma Myeloma & Leukemia article Medicine Multiple Myeloma Research and Treatments Open access
Nizar Jacques Bahlis, Christy Joy Samaras, Donna Ellen Reece, Michaël Sébag, Jeffrey Matous, Jesús G. Berdeja, +12 more
0citations -
1485P Atezolizumab plus bevacizumab before or after transarterial chemoembolization in hepatocellular carcinoma: Interim analysis of the DEMAND (AIO-HEP-0418) randomized phase II clinical trial2025 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Alexander B. Philipp, Najib Ben Khaled, Jens Ricke, Julia V. Mayerle, Dirk Waldschmidt, Ilja Kubisch, +12 more
0citations -
WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL
Jonathan Barratt, Jens Halkjaer Kristensen, Andrew M. Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +6 more
0citations -
Daratumumab + Bortezomib/Lenalidomide/Dexamethasone in (D-VRd) Transplant-Eligible (TE) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) in the Phase 3 PERSEUS Study
Pieter Sonneveld, Philippe Moreau, Meletios Athanasios Dimopoulos, Hang Quach, P. Joy Ho, Meral Beksaç, +35 more
0citations -
Further analysis of phase III, single-dose, open-label study to investigate the efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging during cytoreductive surgery of folate receptor-positive ovarian cancer (NCT03180307)
Janos Laszlo Tanyi, Leslie M. Randall, Setsuko K. Chambers, Kristina A. Butler, Ira Seth Winer, Carrie L. Langstraat, +8 more
0citations